Apnimed
Headquarters country
United States
Registry sponsor category
Industry
- Company name
- Apnimed
- Organisation type
- Industry
- Registered legal name
- Apnimed, Inc.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- Apnimed
- Apnimed Inc.
- SEC filer number (CIK)
- 0001745648
Related records
Trials (19)
- AD109 Dose Finding in Mild to Moderate OSA
- AD816 Crossover Study
- Adherence to Health Coaching with Wearable Devices: Enhancing Patient Engagement and Outcomes
- Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea
- Continuation Protocol for Obstructive Sleep Apnea (OSA)
- Crossover Trial of AD036 in Obstructive Sleep Apnea
- Crossover Trial of AD109 in Obstructive Sleep Apnea
- Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
- Effect of AD128 to Treat Obstructive Sleep Apnea
- Parallel Arm Trial of AD109 and AD504 In Patients With OSA
- Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
- Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
- Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing
- Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)
- Study of AD128 Versus Placebo in Obstructive Sleep Apnea
- Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome
- Study That Tests AD109 in Patients Taking GLP-1 Drugs
- Trial of AD036 in Obstructive Sleep Apnea
- Trial of AD113 and Atomoxetine in OSA Patients With Hypertension